Angus C. Russell - Net Worth and Insider Trading

Angus C. Russell Net Worth

The estimated net worth of Angus C. Russell is at least $177,999 dollars as of 2024-05-22. Angus C. Russell is the Director of Lineage Cell Therapeutics Inc and owns about 87,500 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $91,875. Angus C. Russell is the Director of Revance Therapeutics Inc and owns about 26,913 shares of Revance Therapeutics Inc (RVNC) stock worth over $82,219. Angus C. Russell is also the Director of TherapeuticsMD Inc and owns about 1,870 shares of TherapeuticsMD Inc (TXMD) stock worth over $3,905. Besides these, Angus C. Russell also holds Mallinckrodt PLC (MNKKQ) . Details can be seen in Angus C. Russell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Angus C. Russell has not made any transactions after 2021-12-13 and currently still holds the listed stock(s).

Transaction Summary of Angus C. Russell

To

Angus C. Russell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Angus C. Russell owns 5 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , TherapeuticsMD Inc (TXMD) , and Revance Therapeutics Inc (RVNC) among others .

Click here to see the complete history of Angus C. Russell’s form 4 insider trades.

Insider Ownership Summary of Angus C. Russell

Ticker Comapny Transaction Date Type of Owner
LCTX Lineage Cell Therapeutics Inc 2021-06-29 director
TXMD TherapeuticsMD Inc 2022-08-18 director
RVNC Revance Therapeutics Inc 2021-12-13 director
2022-06-16 director
2022-06-16 director

Angus C. Russell Latest Holdings Summary

Angus C. Russell currently owns a total of 4 stocks. Among these stocks, Angus C. Russell owns 87,500 shares of Lineage Cell Therapeutics Inc (LCTX) as of June 29, 2021, with a value of $91,875 and a weighting of 51.62%. Angus C. Russell owns 26,913 shares of Revance Therapeutics Inc (RVNC) as of December 13, 2021, with a value of $82,219 and a weighting of 46.19%. Angus C. Russell also owns 1,870 shares of TherapeuticsMD Inc (TXMD) as of August 23, 2019, with a value of $3,905 and a weighting of 2.19%. The other 1 stocks Mallinckrodt PLC (MNKKQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Angus C. Russell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2021-06-29 87,500 1.05 91,875
RVNC Revance Therapeutics Inc 2021-12-13 26,913 3.06 82,219
TXMD TherapeuticsMD Inc 2019-08-23 1,870 2.09 3,905
MNKKQ Mallinckrodt PLC 2020-11-12 0 0.02 0

Holding Weightings of Angus C. Russell


Angus C. Russell Form 4 Trading Tracker

According to the SEC Form 4 filings, Angus C. Russell has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 4,720 shares on June 29, 2021, which brought Angus C. Russell around $14,018.

According to the SEC Form 4 filings, Angus C. Russell has made a total of 1 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 6,400 shares on December 13, 2021, which cost Angus C. Russell around $100,736.

According to the SEC Form 4 filings, Angus C. Russell has made a total of 2 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TherapeuticsMD Inc is the acquisition of 200 shares on August 23, 2019, which cost Angus C. Russell around $27,700.

More details on Angus C. Russell's insider transactions can be found in the Insider Trading History of Angus C. Russell table.

Insider Trading History of Angus C. Russell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Angus C. Russell Trading Performance

GuruFocus tracks the stock performance after each of Angus C. Russell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Angus C. Russell is 0.2%. GuruFocus also compares Angus C. Russell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Angus C. Russell within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Angus C. Russell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Angus C. Russell

Average Return

Average return per transaction

Outperforming Transactions

3 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.69
Relative Return to S&P 500(%) 12.47

Angus C. Russell Ownership Network

Ownership Network List of Angus C. Russell

No Data

Ownership Network Relation of Angus C. Russell


Angus C. Russell Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Who are the key executives at Lineage Cell Therapeutics Inc?

Angus C. Russell is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and director & President and CEO Brian M Culley .

Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary

Over the past 18 months, Angus C. Russell made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,000 shares made by Anula Jayasuriya .

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,836,925 shares were bought by its insiders, resulting in a net purchase of 6,836,925 shares.

Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lineage Cell Therapeutics Inc Insider Transactions

No Available Data

Angus C. Russell Mailing Address

Above is the net worth, insider trading, and ownership report for Angus C. Russell. You might contact Angus C. Russell via mailing address: C/o Intermune, Inc., 3280 Bayshore Boulevard, Brisbane Ca 94005.

Discussions on Angus C. Russell

No discussions yet.